International

PARAGON – the study that drove ANZGOG’s position at the forefront of innovative trial designs

Led by ANZGOG co-founder Professor Michael Friedlander AM, PARAGON was one of ANZGOG's first practice-changing studies. The publications arising from the insights and data collected because of this pivotal trial continue to contribute to research on [...]

PARAGON – the study that drove ANZGOG’s position at the forefront of innovative trial designs2023-10-18T11:45:30+11:00

New Publication for the PHAEDRA study (PHAse 2 trial of DuRvalumab in Advanced Endometrial Cancer)  

A new journal has been published by the Journal for ImmunoTherapy of Cancer for ANZGOG's PHAEDRA study. The PHAEDRA study examined the activity of the immunotherapeutic agent durvalumab in women with advanced endometrial cancer that [...]

New Publication for the PHAEDRA study (PHAse 2 trial of DuRvalumab in Advanced Endometrial Cancer)  2021-07-22T23:34:55+10:00
Go to Top